Can clinical benefits of modulators effectively 'modulate' adherence in people with CF?
- PMID: 33863830
- DOI: 10.1136/thoraxjnl-2021-216974
Can clinical benefits of modulators effectively 'modulate' adherence in people with CF?
Keywords: cystic fibrosis.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study.Thorax. 2021 Sep;76(9):874-879. doi: 10.1136/thoraxjnl-2020-215556. Epub 2021 Feb 12. Thorax. 2021. PMID: 33579778
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources